November 6, 1990

A nonsteroidal anti-inflammatory drug which is phenylacetic acid derivative and methods of using the same in topically controlling eye inflammations.

17

November 6, 1990

07/147,974

January 25, 1988

514/532   514/570

A61K   31/19   (20060101)   A61K   31/22   (20060101)   A61K   31/185   (20060101)   A61K   31/21   (20060101)  

514/532   514/570  

5401510 - Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation - Owned by Alcon Laboratories, Inc. (Fort Worth, TX) [*] Notice:The portion of the term of this patent subsequent to December 21, 2010 has been disclaimed. Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.

5225424 - Methazolamide-derived carbonic anhydrase inhibitors - Owned by University of Iowa Research Foundation (Oakdale, IA) N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)ylidene] -2-acetyloxyacetamide, commonly referred to as acetylhydroxymethazolamide and is a water soluble pharmacologically active carbonic anhydrase inhibitor.